1
|
Tomasello L, Carlucci L, Laganà A, Galletta S, Marinelli CV, Raffaele M, Zoccolotti P. Neuropsychological Evaluation and Quantitative EEG in Patients with Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment. Brain Sci 2023; 13:930. [PMID: 37371408 DOI: 10.3390/brainsci13060930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Revised: 05/25/2023] [Accepted: 06/05/2023] [Indexed: 06/29/2023] Open
Abstract
This study analyzed the efficacy of EEG resting state and neuropsychological performances in discriminating patients with different forms of dementia, or mild cognitive impairment (MCI), compared with control subjects. Forty-four patients with dementia (nineteen patients with AD, and seven with FTD), eighteen with MCI, and nineteen healthy subjects, matched for age and gender, underwent an extensive neuropsychological test battery and an EEG resting state recording. Results showed greater theta activation in posterior areas in the Alzheimer's disease (AD) and Fronto-Temporal Dementia (FTD) groups compared with the MCI and control groups. AD patients also showed more delta band activity in the temporal-occipital areas than controls and MCI patients. By contrast, the alpha and beta bands did not discriminate among groups. A hierarchical clustering analysis based on neuropsychological and EEG data yielded a three-factor solution. The clusters differed for several neuropsychological measures, as well as for beta and theta bands. Neuropsychological tests were most sensitive in capturing an initial cognitive decline, while increased theta activity was uniquely associated with a substantial worsening of the clinical picture, representing a negative prognostic factor. In line with the Research Domains Framework (RDoC) perspective, the joint use of cognitive and neurophysiological data may provide converging evidence to document the evolution of cognitive skills in at-risk individuals.
Collapse
Affiliation(s)
- Letteria Tomasello
- Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy
- Faculty of Medicine and Dentistry, Sapienza University of Rome, 00185 Rome, Italy
| | - Leonardo Carlucci
- Learning Sciences Hub, Department of Humanities, Letters, Cultural Heritage and Educational Studies, Foggia University, 71121 Foggia, Italy
| | - Angelina Laganà
- Department of Biomedical and Dental Sciences, Morphological and Functional Images, 98122 Messina, Italy
| | - Santi Galletta
- Réseau Hospitalier Neuchâtelois (RHNe), Service de Neurologie et Neuroréadaptation, 2000 Neuchâtel, Switzerland
| | - Chiara Valeria Marinelli
- Learning Sciences Hub, Department of Humanities, Letters, Cultural Heritage and Educational Studies, Foggia University, 71121 Foggia, Italy
| | - Massimo Raffaele
- Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy
| | - Pierluigi Zoccolotti
- Tuscany Rehabilitation Clinic, 52025 Montevarchi, Italy
- Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy
| |
Collapse
|
2
|
Giussani G, Enia G, Bianchi E, Mecarelli O, Beghi E, Cagnetti C, Baldinelli S, Lattanzi S, La Neve A, Tappatà M, Francavilla T, De Maria G, Sofia V, Giuliano L, Mainieri G, Fatuzzo D, Belcastro V, Elia M, D'Orsi G, Lalla A, Salmaggi A, Brigo F, Magaudda A, Pisani F, Galletta S, Pisani LR, Raffaele M, Cosenza D, Villani FS, Quintas RM, Cervellione R, Borroni S, Meletti S, Ferrarese C, Barbella G, Di Francesco J, Bogliun G, Beretta S, Galimberti CA, Cantisani TA, Cecconi M, Celani MG, Papetti R, Giorgi FS, Aguglia U, Gasparini S, Ferlazzo E, Manganotti P, Crichiutti G, Bravar G. The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study. Epilepsy Behav 2020; 102:106641. [PMID: 31759314 DOI: 10.1016/j.yebeh.2019.106641] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Accepted: 10/01/2019] [Indexed: 11/24/2022]
Abstract
PURPOSE The purpose of this study was to assess the priorities of patients with epilepsy and caring physicians and the correspondence between these priorities. METHODS In this multicenter cross-sectional study, patients with epilepsy attending 21 Italian epilepsy centers and their caring physicians filled anonymously questionnaires on the needs and priorities in the management of the disease. Included were questions on patients' demographics, diagnosis, treatment, and outcome of epilepsy. The concordance between patients and their physicians was assessed on various aspects of the diagnosis and care of the disease. Patients' satisfaction with communication, services, and patient-doctor relationship was also assessed. RESULTS Included were 432 women and 355 men aged 15 to 88 years (median: 41 years). Disease duration ranged from 6 months to 75 years. A structural/metabolic etiology predominated (52.7%), followed by a (presumed) genetic etiology (33.0%). Seizure remission was present in 56.5% of cases. Comorbidities requiring chronic treatment were present in 27.5%, and comorbidities affecting self-sufficiency in 9.5%. Psychiatric comorbidity was present in 35.0%. Patients' priorities included discovery of the cause (89.1%), use of right drug (98.7%), use of a drug without chronic side effects (94.0%), and a life without restrictions (90.4%). Physicians' priorities included choice of right drug (83.5%) and use of drugs without chronic side effects (86.8%). Priorities varied with patients' age, sex, education, and occupation. Patient-doctor relationships were at least good in most cases. The information imparted was considered unsatisfactory by 21-44% of cases on seizure circumstances and complications, side effects of drugs, limitations of daily activities, and management of physiologic or pathologic conditions. Patients declared overall satisfaction, except for appointments (21.5%) and emergencies (30.8%). CONCLUSION Patients and physicians' priorities in the management of epilepsy overlap only in part. Patients are satisfied with their caring physicians and less satisfied with communication and management of routine and emergency problems.
Collapse
Affiliation(s)
- Giorgia Giussani
- Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy
| | - Gabriele Enia
- Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy
| | - Elisa Bianchi
- Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy
| | - Oriano Mecarelli
- Dipartimento Neuroscienze Umane, Sapienza Università di Roma, Italy
| | - Ettore Beghi
- Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Vanella L, Li Volti G, Distefano A, Raffaele M, Zingales V, Avola R, Tibullo D, Barbagallo I. A new antioxidant formulation reduces the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells. Eur Rev Med Pharmacol Sci 2017; 21:5478-5484. [PMID: 29243793 DOI: 10.26355/eurrev_201712_13938] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE In this study we evaluated the possible protective effect of an antioxidant formulation containing microfiltered milk derived polypeptides, Curcumin, Vitamin B2, Carnitine and N-Acetyl-cysteine (NAC) in an in vitro model of chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS Human bronchial epithelial cells (16HBE) were used in this study. Cells were treated for 24 h in the presence or absence of 10% of cigarette smoke extract (CSE) and in the presence or absence of antioxidant formulation. We evaluated cell viability by MTT assay, reactive oxygen species by flow cytometer and quantitative analysis of gene expression by Real-time PCR. RESULTS The data obtained showed a significant increase of cell viability in CSE-exposed cells and a significant reduction of reactive oxygen species (ROS) production compared to cells treated with only CSE. The antioxidant effects of formulation were confirmed by a decrease of inflammatory cytokines genes IL-1β, IL-6, TNFα, nitric oxide synthase gene (NOS2) and through an induction of antioxidant genes such as heme oxygenase 1 (HO-1), nuclear transcription factor erythroid 2 (NRF2) and peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α). CONCLUSIONS The results suggest that antioxidants combination plays a protective role on oxidative stress and inflammation, in an in vitro model of COPD, activating key genes in response to oxidative stress and decreasing the cytokines responsible for the inflammatory pathways.
Collapse
Affiliation(s)
- L Vanella
- Department of Drug Science, Biochemistry Section, University of Catania, Catania, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Mafodda A, Giannicola R, Azzarello D, Del Medico P, Raffaele M, Giuffrè C, Maisano R. Effectiveness and safety of Everolimus-Exemestane (EVE-EXE) in unselected patients (pts) with HR + /HER2- Metastatic Breast Cancer (MBC): Our experience in clinical practice. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw337.58] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
5
|
Nardi M, Azzarello D, Maisano R, Del Medico P, Giannicola R, Raffaele M, Zavettieri M, Costarella S, Falzea A. FOLFOX-4 Regimen as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer: A Safety Study. J Chemother 2013; 19:85-9. [PMID: 17309856 DOI: 10.1179/joc.2007.19.1.85] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Gastric cancer is often diagnosed in advanced stage (AGC) and in elderly patients. Current chemotherapies induce severe toxicity and are difficult to deliver. Some authors have shown the activity and safety of oxaliplatin with various 5-fluorouracil (FU) and leucovorin (LV) infusions in AGC. The aim of our study was to evaluate the feasibility of the FOLFOX-4 regimen in elderly patients with AGC. From 6/2003 to 7/2005, 33 patients (median age 74 years, range 66-79 years) were enrolled into the study. 31 patients were assessable for the safety analysis and for response. We recorded complete response in 4 patients (13%), partial response in 6 patients (19%), 9 (29%) stable disease and 12 progressive disease for an overall response rate of 32% (95% CI, 16% to 48%). At median follow-up of 20 months the median time to progression was 6.4 months. The therapy was well tolerated, the main G1/2 toxicities were nausea, vomiting and diarrhea. Only 2 patients suffered from severe vomiting. Severe hematologic toxicities were uncommon. Anemia G3 was recorded in 3 patients, neutropenia G3 in 6 patients and febrile neutropenia in 1 patient. G1 and G2 neurotoxicity were a common event while G3 sensorial neuropathy was not reported. We conclude that although our patients were elderly and most had a PS 2, the regimen was manageable, easy to deliver, well accepted by the patients and active.
Collapse
Affiliation(s)
- M Nardi
- U.O. di Oncologia Medica, Reggio Calabria, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Maisano R, Zavettieri M, Azzarello D, Raffaele M, Maisano M, Bottari M, Nardi M. Carboplatin and gemcitabine combination in metastatic triple-negative anthracycline- and taxane-pretreated breast cancer patients: a phase II study. J Chemother 2011; 23:40-3. [PMID: 21482494 DOI: 10.1179/joc.2011.23.1.40] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Triple-negative breast cancer (TNBC) is characterized by lack of hormone receptors and HER-2 and shares many features with BRCA1-associated cancer. Preclinical data indicate cisplatin sensitivity, suggesting that these tumors may have defects in the BRCA1 pathway. The carboplatin and gemcitabine (CG) combination is active in unselected anthracycline/taxane pretreated metastatic breast cancer patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic TNBC patients. From 10/2004 to 3/2009 we enrolled 31 patients. Median age was 57 years and 29 patients out of 31 had visceral involvement. The overall response rate (ORR) was 32% (1 complete response /9 partial responses), in addition 5 patients obtained stable disease for >12 weeks. After a median follow-up of 34 months, all patients progressed with a median time to progression of 5.5 months and median overall survival of 11 months. Dose reductions, delays and omissions occurred in 75 (60%), 36 (29%) and 22 (18%) cycles. Grade 3/4 neutropenia occurred in 17 and febrile neutropenia in 4 patients. Ten patients had Grade 3/4 thrombocytopenia. Non hematological toxicities were manageable. The CG combination is a reasonable option for the treatment of metastatic pretreated TNBC patients.
Collapse
Affiliation(s)
- R Maisano
- Unità Operativa di Oncologia Medica, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
| | | | | | | | | | | | | |
Collapse
|
7
|
Locatelli C, Raffaele M, Cicerchia M, Spazzafumo L, Sebastiani M, Repetto L. 4000 Frailty in elderly patients: winograd and vulnerable elders survey-13 criteria applied to INRCA comprehensive geriatric assessment database. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70734-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
8
|
Repetto L, Piselli P, Raffaele M, Cicerchia M, Locatelli C. 4001 The role of family caregivers of elderly cancer patients in the choice of non disclosure – a GIOGer study. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70735-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
9
|
Maisano R, Maisano R, Azzarello D, Del Medico P, Giannicola R, Giuffrè C, Panuccio V, Raffaele M, Zavettieri M, Falzea A, Nardi M. Incidence of arthralgia syndrome (AS) related to aromatase inhibitors (AIs) in postmenopausal women with early breast cancer (EBC). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e11603] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e11603 Background: Anastozole (A) and letrozole (L) are standard drugs in up-front adjuvant endocrine therapy in postmenopausal hormone positive EBC. AIs have a higher incidence of osteoporosis, bone fractures and musculoskeletal symptoms, particularly joint pain and stiffness (AS) respect to tamoxifen. The real incidence of AS can be underestimated respect to data derived from clinical trials. Methods: From 1/07 to 12/07 we registered all patients (pts) taking A or L as adjuvant therapy for at least 3 months. We screened 47 pts, 3 pts refused to participate at the study and 2 resulted metastatic. A total of 42 pts were enrolled. The median age was 67 yrs (range 51–89), the median time since menopause was 11 yrs (range 1–48). 30 pts had natural menopause, 7 surgical menopause and 5 reported chemo-induced menopause. 25 pts took A and 17 pts took L. The median duration on therapy was 19 months (range 3–68) and 31 pts had received chemotherapy (9 CMF, 17 anthra-based, 5 anthra-taxane based). Results: 11 pts (26%) did not report AS, 19 pts (45%) had new-onset AS and 12 (29%) had worsening of prior joint pain after starting adjuvant AIs therapy. Most pts reported moderate to severe AS requiring occasional use of nonsteroidal anti-inflammatory drugs (75%), 15% used oral supplements and 10% used opiates, only 4 women used exercise to relieve joint stiffness. 17 pts interrupted the therapy from 7 to 20 days in order to reduce the symptoms and 7 obtained a partial improvement. 11 pts (35%) suffered from AS declared the worsening of quality of life. In univariate analysis presence of AS was not associated with age, entry into menopause, years since menopause, duration of AI therapy or previous chemotherapy. Conclusions: Our data show a higher incidence of AS in clinical practice respect to literature data, which caused worsening of quality of life and could be reason of discontinuation of effective therapy. The exact mechanism of AIs-related arthralgia is unclear, but is believed to be related to estrogen deprivation, however further studies are needed to define the pathogenesis in order to find an effective therapy. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Maisano
- Oncologia Medica, Reggio Calabria, Italy
| | - R. Maisano
- Oncologia Medica, Reggio Calabria, Italy
| | | | | | | | - C. Giuffrè
- Oncologia Medica, Reggio Calabria, Italy
| | | | | | | | - A. Falzea
- Oncologia Medica, Reggio Calabria, Italy
| | - M. Nardi
- Oncologia Medica, Reggio Calabria, Italy
| |
Collapse
|
10
|
Repetto L, Locatelli C, Raffaele M, Di Bartolomeo C, Sebastiani M, Spazzafumo L. The use of Winograd and Vulnerable Elders Survey-13 criteria to evaluate frailty applied to INRCA Comprehensive Geriatric Assessment database. Crit Rev Oncol Hematol 2008. [DOI: 10.1016/s1040-8428(08)70041-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
11
|
Nardi M, Azzarello D, Del Medico P, Giannicola R, Falzea A, Giuffrè C, Maisano R, Panuccio V, Raffaele M, Zavettieri M, Avallone A. Metronomic irinotecan and standard FOLFIRI regimen as first-line chemotherapy in metastatic colorectal cancer (MCRC). Final results of phase II study. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.14520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
14520 Background: Angiogenesis is necessary to sustain the growth of both the primary tumour and the development of metastases in colorectal cancer. Before the clinical use of bevacizumab, metronomic chemotherapy was the only mean to block the growth of tumor microvessel. CPT-11 showed, in preclinical model, to have antiangiogenetic properties using low doses and weekly administration. We carried out this study in order to evaluate the activity and toxicity of mixed metronomic and standard FOLFIRI regimen in MCRC. Methods: From 10/03 to 9/05 we treated 46 pts (24M 22F), median age 66 years (range 41–79), ECOG PS 0–2 with this schedule: CPT- 11 10 mg/mq days 1, 7, 10 and CPT-11 150 mg/mq day 2, l-Folinic Acid 100 mg/mq days 2 and 3, 5-FU 400 mg/mq bolus days 2 and 3 and 5- FU 600 mg/mq 44 hours c.i. days 2 and 3 every two weeks for a maximum of 12 cycles. Results: All pts have been evaluable activity and toxicity. We obtained 9 CR (20%), 12 PR (26%) with an ORR of 46% (CI 95%: ±13%) and 17 SD. After a median follow-up of 24 months we registered a median TTP of 10 months and a median OS of 22 months. As regard toxicity, the chemotherapy has been well tolerated; no toxic deaths occurred and no therapy ended for toxicity. 6 pts had 25% dose reduction (standard schedule) for diarrhea G4 after the first cycle. The main toxicities recorded on a total of 440 cycles (cy) delivered were: diarrhea G4 1.7% and G3 2.3% of the cy. Neutropenia G3 5.8% and vomiting G3 0.5% of the cy. Anemia G2 was recorded in 14 pts. All pts suffered from partial alopecia and half of the pts from mild oral mucositis. Conclusions: This mixed schedule seems to be active and well tolerated, ORR, TTP and OS are similar to Hurwitz results (NEJM 2004; 350: 2335–42) but with less adverse events. The combination of this schedule with bevacizumab deserves further studies. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- M. Nardi
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - D. Azzarello
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - P. Del Medico
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - R. Giannicola
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - A. Falzea
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - C. Giuffrè
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - R. Maisano
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - V. Panuccio
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - M. Raffaele
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - M. Zavettieri
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| | - A. Avallone
- Azienda Ospedaliera, Reggio Calabria, Italy; IRCCS, Napoli, Italy
| |
Collapse
|
12
|
Azzarello D, Giuffrè C, Panuccio V, Giannicola R, Del Medico P, Zavettieri M, Raffaele M, Maisano R, Falzea A, Nardi M. First line chemotherapy with FOLFOX 4 in elderly patients (>65 years) with advanced or metastatic gastric cancer (A/MGC): A pilot study. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.14095] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
14095 Background: Cisplatin/5-FU based regimens are considered therapies of choice for the treatment of A/MGC even if severe toxicities are reported especially in elderly pts. FOLFOX 4 regimen is standard chemotherapy in adjuvant and metastatic colorectal cancer and it is effective and well tolerated also in elderly population. Several trials have showed activity and safety of FOLFOX regimen in A/MGC. For these reasons, we carried out this pilot study in order to evaluate the feasibility of FOLFOX 4 in elderly pts (>65 yrs) with A/MGC. Methods: From June 2003 to June 2005 we treated with FOLFOX 4 regimen 31 pts with median age of 70 yrs (range 66–79), 20 males and 11 females, ECOG PS 0–2 with MGC in 19 cases and AGC in 12 cases. All pts had measurable disease according to RECIST criteria, NCI-CTC was employed to grade toxicity except for neurotoxicity graded by specific scale. Results: We recorded 4 CR (13%), 6 PR (19%), 9 SD (29%) and 12 PD for an ORR 32% and median TTP of 6.8 months. A total of 281 courses were delivered with a median of 8 courses (range 4–15) per pt. No toxic deaths occurred and no therapy has been ended for toxicity or pt refusal. Pts did not receive G-CSF support. 43 courses were delayed for toxicity (maximum 2 weeks). Haematological adverse events were: 23 episodes of neutropenia G1/2, 8 episodes of G3 and 3 episodes of G4 neutropenia; G1/2 thrombocytopenia occurred in 15 episodes; anemia G1/2 was reported in 13 episodes. Besides, we recorded 12 episodes of emesis G2 and 2 episodes of G3; 24 episodes of G1/2 and 7 episodes of G3 oral mucositis were recorded; diarrhoea G1/2 was a common event (around 50% of cycles) while severe diarrhoea was a rare. Alopecia G1/2 was registered in 19 pts, G1neurosensorial toxicity (specific scale) occurred in 16 pts, G2 in 7 pts and G3 in one pt. One pt had hypersensitivity reaction at first infusion that did not occurred anyone by prolonged infusion of L-OHP. Conclusions: Our data show that FOLFOX 4 is active in the treatment of A/MGC and that toxicity profile is favourable in elderly population in comparison to standard regimens. No significant financial relationships to disclose.
Collapse
Affiliation(s)
| | - C. Giuffrè
- Azienda Ospedaliera, Reggio Calabria, Italy
| | | | | | | | | | | | - R. Maisano
- Azienda Ospedaliera, Reggio Calabria, Italy
| | - A. Falzea
- Azienda Ospedaliera, Reggio Calabria, Italy
| | - M. Nardi
- Azienda Ospedaliera, Reggio Calabria, Italy
| |
Collapse
|
13
|
Ferlazzo E, Raffaele M, Mazzù I, Pisani F. Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy. Epilepsy Behav 2006; 8:328-30. [PMID: 16343998 DOI: 10.1016/j.yebeh.2005.11.005] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2005] [Revised: 10/15/2005] [Accepted: 11/03/2005] [Indexed: 11/29/2022]
Abstract
Hashimoto's encephalopathy (HE) is a severe but treatable condition that rarely complicates Hashimoto's thyroiditis. Clinically it is characterized by progressive or relapsing symptoms, including tremor, myoclonus, stroke-like episodes, seizures, impairment of consciousness, and dementia. We describe a patient presenting with recurrent generalized convulsive status epilepticus (GCSE), despite antiepileptic medications, who was successfully treated with methylprednisolone. Our observation confirms that the clinical spectrum of HE at presentation is heterogeneous and diagnosis is often difficult. This case highlights the crucial importance of antithyroid antibody measurement in patients presenting with otherwise unexplained episodes of GCSE with or without adjunctive signs of encephalopathy or thyroiditis.
Collapse
Affiliation(s)
- Edoardo Ferlazzo
- Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy
| | | | | | | |
Collapse
|
14
|
Nardi M, Azzarello D, Avallone A, Raffaele M, Giannicola R, Carboni R, Zavettieri M, Del Medico P, Falzea A, Maisano R. Metro-FOLFIRI as first line chemotherapy in metastatic colorectal cancer (MCRC). Preliminary report of a phase II trial. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.3722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. Nardi
- Azienda Osp, Reggio Calabria, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Gallelli L, Nardi M, Prantera T, Barbera S, Raffaele M, Arminio D, Pirritano D, Colosimo M, Maselli R, Pelaia G, De Gregorio P, De Sarro GB. Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer. Pharmacol Res 2004; 49:259-63. [PMID: 14726222 DOI: 10.1016/j.phrs.2003.10.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the world. Traditional chemotherapy for advanced NSCLC is often considered excessively toxic. Recent clinical trials documented that gemcitabine may represent a good therapeutical option in patients with NSCLC. Aim of our research was to retrospectively evaluate the adverse effects induced by gemcitabine in patients with NSCLC from 1 January 1997 to 31 December 2002, in clinical records of Oncology Divisions of "S. Giovanni di Dio" Hospital of Crotone, "Ospedali Riuniti" Hospital of Reggio Calabria, Hospital of Paola, and in Pneumological Oncology Division of "Mariano Santo" Hospital of Cosenza, Italy. Clinical records of patients treated with gemcitabine (1000mgm(-2) on days 1 and 8) were reviewed and following data were obtained: sex and age of the patients, histologic diagnosis and disease stage, World Health Organisation (WHO) performance status and toxic effects induced by gemcitabine. We reported that 71.6% of NSCLC patients (age range 48-77 years; 135 males, 27 females; performance status 0=53, 1=109) were eligible for our study. Side effect of gemcitabine involved gastrointestinal system (nausea, vomiting and diarrhoea) and only in the last cycles (VIII-XI) emopoiethic system (leukopenia, neutropenia, thrombocytopenia and anemia). Grade IV vomiting occurred in three patients, thrombocytopenia in two. Grade III leukopenia was observed in three patients. Other toxicities were mild. None of the patients died during chemotherapy. In conclusion, these data showed that gemcitabine present a very good tolerability in patients with NSCLC. Therefore, it could be considered as a new therapeutic agents to use as first line therapy for this disease.
Collapse
Affiliation(s)
- L Gallelli
- Chair of Pharmacology, Department of Experimental and Clinical Medicine, University of Catanzaro, Regional Pharmacovigilance Center, University of Catanzaro, Via T. Campanella 115, 88100, Catanzaro, Italy,
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Nardi M, Mare M, Zavettieri M, Raffaele M, Panuccio V, Azzarello D, Cortese C, Del Medico P, Falzea A. Folfiri (CPT11/LV5FU2) and folfox4 (oxaliplatin/LV5FU2): Two safety regimens in elderly fit patients with metastatic colorectal cancer (MCRC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.3711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. Nardi
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| | - M. Mare
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| | | | - M. Raffaele
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| | - V. Panuccio
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| | - D. Azzarello
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| | - C. Cortese
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| | | | - A. Falzea
- Ospedali Reggio Calabria, Reggio Calabria, Italy
| |
Collapse
|
17
|
Sdrobolini A, Contu A, Massidda B, Gasperoni S, Recchia F, Iannelli A, Tomao S, Romiti A, Raffaele M, Ortu S, Campisi C, Gebbia V, Olmeo N, Ionta MT, Angiona S, Di Costanzo F. 5-Fluorouracil plus Folinic Acid with or without Ifosfamide in Advanced Colorectal Cancer: A Phase II Randomized Trial. Tumori 2000; 86:211-4. [PMID: 10939601 DOI: 10.1177/030089160008600307] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Aim This phase II trial evaluated the biomodulation of 5-fluorouracil (5-FU) plus folinic acid (FA) with or without ifosfamide (IFO) in chemotherapy-naive patients with colorectal cancer. Patients and methods Forty-eight patients were randomized to receive: FA (25 mg/m2 iv bolus days 1 to 3), followed by 5-FU (750 mg/m2 iv bolus days 1 to 3), arm A; or FA (25 mg/m2 iv bolus days 1 to 3), followed by 5-FU (750 mg/m2 iv bolus days 1 to 3) plus IFO (2,000 mg/m2 in 1000 mL 5% dextrose in a 2-hr infusion, days 1 to 3), arm B. Mesna was added during and after IFO to prevent hemorrhagic cystitis. Treatment was repeated every 21 days in both arms. Results Forty-five patients were assessable for response: in arm A, 5 patients achieved a partial response (overall response, 25%), and in arm B, 2 patients achieved a complete and 1 a partial response (overall response, 12%). Time to failure was 3.5 months (range, 1–38) in patients treated with 5-FU plus FA, and 3 months (range, 1–21) in patients treated with the IFO combination. The median survival time was 13.5 months (range, 1–49 months) in arm A and 16 months (range, 1–43 months) in arm B. Diarrhea, stomatitis and vomiting were the most common nonhematologic toxicities in both arms. The most notable hematologic toxicity was leukopenia; 15% and 20% of patients experienced grade 4 in arm A and arm B, respectively. Conclusions IFO does not increase the activity of the 5-FU plus FA combination in advanced colorectal cancer.
Collapse
Affiliation(s)
- A Sdrobolini
- Department of Medicine and Medical Oncology, Santa Maria Hospital, Terni, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Cascinu S, Valenti A, Amadio P, Mare M, Munaò S, Crucitta E, Raffaele M, Picone G, Mesiti M, Gasparini G. Angiosuppression and chemotherapy: strategies aimed at their integration in cancer patients. Int J Biol Markers 1999; 14:239-42. [PMID: 10669952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
A number of antiangiogenic agents have been developed as pharmaceuticals and are currently being tested in clinical studies. Potential strategies to enhance the activity of angiogenesis inhibitors could be to combine them, or better still, to administer them either sequentially or concurrently with cytotoxic drugs. Chemotherapy would be a more appropriate initial choice for patients with advanced disease since cytostatic agents can induce a fast regression of the tumor and cancer-related symptoms. Antiangiogenic treatment could be used after chemotherapy in patients who achieve disease remission to prolong the time to progression, the symptom-free interval and the overall survival. Antiangiogenic treatment is likely to attain an important role in the adjuvant setting. In fact, it could be used for prolonged periods after radical surgery to maintain dormancy of residual tumor cells. In spite of these promising preclinical data, several points need to be clarified before the initiation of clinical trials. In fact, certain misconceptions may interfere with their optimum design and result analysis.
Collapse
Affiliation(s)
- S Cascinu
- Department of Medical Oncology, University of Messina, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Germanò A, Caruso G, Caffo M, Cacciola F, Belvedere M, Tisano A, Raffaele M, Tomasello F. Does subarachnoid blood extravasation per se induce long-term neuropsychological and cognitive alterations? Acta Neurochir (Wien) 1998; 140:805-11; discussion 811-2. [PMID: 9810447 DOI: 10.1007/s007010050182] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Although recent advances in medical and management strategies have reduced the mortality and morbidity rates related to subarachnoid haemorrhage (SAH), patients who survive a SAH may remain nevertheless affected by persistent cognitive and neuropsychological disturbances. The presence of these deficits has been attributed to the neurotoxic effects of the widespread subarachnoid blood. To assess the long-term neuropsychological and cognitive outcome related to subarachnoid blood extravasation per se we evaluated 20 patients affected by an unknown origin subarachnoid haemorrhage, and having SAH characteristics generally considered predictive of a favourable outcome. Patients were enrolled after a one-year interval from the initial insult, and were selected accordingly to a pre-designed protocol. We employed a complete battery of tests, assessing general cognitive and language functions, memory and construction ability, attention and vigilance, anxiety and depression. The results were compared with normal reference values and with performances of a socio-demographically homogenous sample of control volunteers. This study did not evidence any significant long-term cognitive and neuropsychological alteration after subarachnoid blood extravasation. These results indicate that the presence of subarachnoid blood initiate a number of secondary mechanisms of pathology.
Collapse
Affiliation(s)
- A Germanò
- Neurosurgical and Neurological Clinic, University of Messina School of Medicine, Italy
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Tomao S, Romiti A, Mozzicafreddo A, Raffaele M, Zullo A, Antonaci A. Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis. Oncol Rep 1998; 5:723-5. [PMID: 9538184 DOI: 10.3892/or.5.3.723] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
The increased incidence of hepatocellular carcinoma in patients affected with haemochromatosis has previously been attributed to cirrhosis. However, some cases of hepatocellular carcinoma without cirrhosis have recently been reported in patients with haemochromatosis, leading to reconsideration of the role of iron in the tumorigenesis of hepatocellular carcinoma. We describe a 79 year old male patient affected with haemochromatosis and with a multinodular hepatocellular carcinoma, but without any evidence of cirrhosis. The absence of any other cancer risk factor (alcohol abuse, liver viral infections, heredity) has lead us to reconsider the possible role of iron as a direct carcinogen in the onset of hepatocellular carcinoma in patients with haemochromatosis.
Collapse
Affiliation(s)
- S Tomao
- IST, Istituto Nazionale per la ricerca sul cancro, Sezione di Roma, Via A. Baldovinetti 83, Rome, 00142, Italy
| | | | | | | | | | | |
Collapse
|
21
|
Germanò A, Tisano A, Raffaele M, Munaò F, Cacciola F, La Rosa G, Tomasello F. Is there a group of early surgery aneurysmal SAH patients who can expect to achieve a complete long-term neuropsychological recovery? Acta Neurochir (Wien) 1997; 139:507-14. [PMID: 9248583 DOI: 10.1007/bf02750992] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
There is a significant controversy regarding the effect of early surgical intervention for microsurgical aneurysm clipping on long-term cognitive recovery. Although new strategies in surgical and medical management have progressively reduced the morbidity and mortality rates related to subarachnoid haemorrhage (SAH), the overall quality of life of aneurysm patients has been reported to remain unsatisfactory. In fact, even in the presence of a good neurological recovery following an aneurysmal SAH, patients may show persistent emotional and psychological disturbances. The aim of this study was to analyse the long-term cognitive, neuropsychological and emotional status of a group of patients, subjected to early surgery aneurysm treatment, and having SAH characteristics generally considered predictive of a favourable outcome. Patients were submitted to a complete battery of neuropsychological tests designed to assess a full range of cognitive and attentional functions. The results of the neuropsychological evaluation did not detect evidence of any significant cognitive deterioration as compared to control volunteers and to the published age-adjusted test norms. These results indicate that early aneurysm surgery, coupled with modern microneurosurgical techniques and aggressive medical management is associated with a good neurological outcome and a full recovery of cognitive, neuropsychological and emotional performances in a subset of patients with favourable clinical characteristics.
Collapse
Affiliation(s)
- A Germanò
- Neurosurgical Clinic, University of Messina, Italy
| | | | | | | | | | | | | |
Collapse
|
22
|
Silvestri R, Narbone MC, De Domenico P, Di Maria F, Raffaele M. Generalized EEG abnormalities in cluster headache. Ital J Neurol Sci 1996; 17:179. [PMID: 8797076 DOI: 10.1007/bf02000853] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
|
23
|
Tomao S, Mozzicafreddo A, Raffaele M, Romiti A, Papò MA, Campisi C. [Interferons in the therapy of solid tumors]. Clin Ter 1995; 146:491-502. [PMID: 8536432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Belonging to the vast family of cytokines, interferons (IFN) have recently been widely investigated concerning their possible clinical applications, both in virology and oncology. In this field results have been quite mixed but definitely encouraging. The best achievements have been obtained in hematology, and particularly in the treatment of hairy cell leukemia and chronic myelogenous leukemia, but new perspectives have also opened in the therapy of solid tumors, especially in the local treatment of superficial bladder cancer and ovarian cancer, AIDS-related Kaposi's sarcoma and malignant melanoma. IFN have in certain cases showed an efficacy comparable to that of classic treatments but with lower toxicity, and in some tumors they have even improved the results obtained so far, especially in combined therapy. We have here gathered the most recent results concerning the use of IFN in the therapy of solid tumors in order to highlight the new therapeutic opportunities available to clinical oncology.
Collapse
Affiliation(s)
- S Tomao
- Istituto Nazionale per la ricerca sul cancro, Policlinico Umberto I di Roma
| | | | | | | | | | | |
Collapse
|
24
|
Silvestri R, Raffaele M, De Domenico P, Tisano A, Mento G, Casella C, Tripoli MC, Serra S, Di Perri R. Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea. Neurophysiol Clin 1995; 25:66-77. [PMID: 7603414 DOI: 10.1016/0987-7053(96)81034-3] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Twenty-one patients affected by extrapyramidal disorders were polygraphically recorded during spontaneous nocturnal sleep for two consecutive nights to assess their sleep and movement patterns. The patients (pts) sample included: Gilles de La Tourette syndrome (TS, nine pts), neuroacanthocytosis (NA, six pts) and Hungtington's chorea (HC, six pts). Sleep recording included C3/A2, 01/A2, ROC/LOC, submental EMG, EKG, nasal airflow thoracoabdominal respirogram, bilateral anterior tibialis and other EMGs, in relation to the individual distribution of the abnormal movements. According to our observations, abnormal movements always decreased but never ceased completely during sleep. Sleep efficiency (SE) was nearly always poor with a high percentage of wakefulness after sleep onset (WASO) and increased number of arousals. REM sleep was often reduced and in some cases (3 TS pts) incompletely defined as far as its microstructural aspects. Slow wave sleep (SWS) was reduced in HC, normal in NA, and increased in all TS patients with the exception of the two adult subjects more severely affected, while the percentage of stage 2 was not affected. Spindling was increased in NA, HC and in the two most severely affected adult TS patients.
Collapse
Affiliation(s)
- R Silvestri
- Department of Clinical Neurology 1, University of Messina, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Silvestri R, Raffaele M, De Domenico P, Tisano A, Laganà A, Di Perri R. Serotoninergic agents in the treatment of Gilles de la Tourette's syndrome. Acta Neurol (Napoli) 1994; 16:58-63. [PMID: 8073918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
A preliminary trial with fluoxetine, a 5-HT reuptake inhibitor, was carried out on two young male patients (21 and 32 years old) affected by Gilles de la Tourette syndrome. They both underwent a complete neurological evaluation also including neuroradiological, neurophysiological and neuropsychological assessment. Both patients had already been treated with benzodiazepines and amitriptyline; the older one was also given haloperidol and chlorimipramine with definite, but short-lasting improvement. During hospitalization a therapeutic trial with fluoxetine (20 mg/day in the younger patient and 40 mg/day in the older) in association with chlorimipramine (75 mg/day) was initiated, leading to a significant reduction (at least 50%) of abnormal movements and obsessive-compulsive behaviour. The older patient had no side effects while the 21 year old subject complained of insomnia, urinary retention and anorexia; despite the objective improvement, these side effects led us to modify the therapy after the first month. The favourable action of serotoninergic agents on TS symptoms supports the hypothesis that the multiple tics of the syndrome are motor compulsions.
Collapse
Affiliation(s)
- R Silvestri
- Department of Neurology, University of Messina, Italy
| | | | | | | | | | | |
Collapse
|
26
|
Silvestri R, De Domenico P, Raffaele M, Mento G, Di Perri R. Sleep in central nervous system disorders. An up to date. Acta Neurol (Napoli) 1991; 13:577-89. [PMID: 1805557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- R Silvestri
- Clinica Neurologica I, Policlinico Universitario, Messina, Italy
| | | | | | | | | |
Collapse
|
27
|
Silvestri R, Mento G, Raffaele M, De Luca G, Buttini G, Casella C, Tisano A, De Domenico P, Di Rosa AE, Di Perri R. Indole-3-pyruvic acid as a possible hypnotic agent in insomniac subjects. J Int Med Res 1991; 19:403-9. [PMID: 1748233 DOI: 10.1177/030006059101900507] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
In a single-blind study six male patients (mean age 39.5 years) with moderate insomnia were treated with placebo for three nights, 100 mg indole-3-pyruvic acid (IPA) for three nights, 200 mg IPA for three nights, 100 mg IPA for two nights and placebo for two nights. Polygraphic recordings were made and total sleep time, sleep efficiency, sleep latency, slow wave sleep latency, rapid eye movement (REM) sleep latency, number of arousals (greater than 1 min), percentage and duration of wakefulness after sleep onset, percentage and duration of wakefulness after sleep onset, percentage and duration of sleep stages 1, 2, 3, 4 and REM were recorded. At the end of 13 days, total sleep time, duration of stage 2 sleep and total non-REM were significantly increased when compared with baseline. Total sleep time and duration of stage 2 and total non-REM sleep on completion were significantly decreased when compared with after 200 mg IPA (night 9). Results suggest an action of IPA on human sleep similar to that of exogenous melatonin and L-tryptophan, thus confirming that IPA could be used to increase serotonin and melatonin turnover.
Collapse
Affiliation(s)
- R Silvestri
- Neurological Clinic I, University of Messina, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Raffaele M, Silvestri R, De Domenico P, Di Perri R. [Gilles de la Tourette disease: review of the literature]. Riv Neurol 1991; 61:145-9. [PMID: 1687713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The authors reviewed recent literature reports on Gilles de la Tourette syndrome. Clinical aspects, etiopathogenetic theories and therapeutic trials were taken into account, to better define the disease and its rational therapeutic approach.
Collapse
Affiliation(s)
- M Raffaele
- Clinica Neurologica I, Università di Messina
| | | | | | | |
Collapse
|
29
|
Silvestri R, Montagnese C, De Domenico P, Raffaele M, Casella C, Lombardo N, Di Perri R. Narcolepsy and psychopathology. A case report. Acta Neurol (Napoli) 1991; 13:275-8. [PMID: 1927635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The case of a 14-year-old girl presenting with the association of a clearcut narcoleptic syndrome and psychiatric disturbances is reported. Tricyclic anti-depressant drugs and hypnagogic hallucinations seem to play a precipitating role on delusional episodes in a predisposed subject with a positive psychiatric familial history.
Collapse
Affiliation(s)
- R Silvestri
- Clinica Neurologica I, Università di Messina, Italy
| | | | | | | | | | | | | |
Collapse
|
30
|
Russi EG, Gaeta M, Pergolizzi S, d'Aquino A, Mesiti M, Raffaele M, Di Carlo M, Delia P, Romeo F. [Pelvic carcinomatous neuropathy: clinical, radiologic, therapeutic implications]. G Ital Oncol 1990; 10:77-84. [PMID: 2286396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Carcinomatous involvement of the pelvic nerves (Pelvic Carcinomatous Neuropathy-PCN-) causes disabling sensorial and motor disturbances of the lower extremities. Recurrent rectal carcinomas are the most common cause of PCN because surgical obliteration of the perirectal fascia. In 31 cases of PCN Authors describe the types of the neoplasm and the sites of involvement of the pelvic nerves evaluating clinical syndromes and Computed Tomography. The results of radiotherapy (doses between 36-56 Gy) in 14 cases of PCN by recurrent rectal cancer are also reported. Although the survival of such patients is poor, radiotherapy has obtained a good palliative result in 50% of them. Personalization of radiation treatment planning is advisable in order to avoid acute side-effects.
Collapse
Affiliation(s)
- E G Russi
- Istituto di Clinica Oncologica e di Ricerca sui Tumori, Università degli Studi di Messina
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Silvestri R, De Domenico P, Raffaele M, Lombardo N, Casella C, Gugliotta MA, Meduri M. Vascular compression from goiter as an unusual cause of cerebrovascular accident. Ital J Neurol Sci 1990; 11:307-8. [PMID: 2387705 DOI: 10.1007/bf02333865] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The unusual case of a patient with goiter and left faciobrachiocrural paresis due to right temporoparietal infarction is reported. Cerebral angioscintigram and arteriography showed a brachiocephalic and right subclavian stenosis secondary to compression by an extended thyroid nodule.
Collapse
Affiliation(s)
- R Silvestri
- Clinica Neurologica I, Università di Messina
| | | | | | | | | | | | | |
Collapse
|
32
|
Narbone MC, D'Amico D, Magaudda A, Raffaele M, Lombardo N, Di Perri R. Distribution of Migraine in Patients with Occipital Epilepsy. Cephalalgia 1989. [DOI: 10.1177/0333102489009s10171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
33
|
Silvestri R, Marabello L, Lasco A, Mento G, Raffaele M, Leuzzi R, Lombardo N, Di Perri R. Wakefulness and sleep autonomic dysfunction in diabetics. Funct Neurol 1989; 4:189-91. [PMID: 2737509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Parasympathetic and sympathetic controls on cardiovascular systems were studied during wakefulness and sleep in 8 diabetic patients (3 IDDM and 5 NIDDM), in order to detect the presence of autonomic dysfunction. In particular, cardiovascular assessment during sleep allowed to detect minimal autonomic abnormalities in the absence of a documented pathology during wakefulness.
Collapse
Affiliation(s)
- R Silvestri
- Second Department of Neurology, University of Messina, Italy
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Silvestri R, De Domenico P, Raffaele M, Xerra A, Di Perri R. Hypnogenic paroxysmal dystonia: a new type of parasomnia? Funct Neurol 1988; 3:95-103. [PMID: 3391405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Four cases of hypnogenic paroxysmal dystonia are described. The patients (three males and one female), aged between 12 and 39 were subjected to neurological, physical and psychological examination, and routine lab tests and brain CT scan were carried out within normal limits. One of the patients suffered from diurnal epileptic seizures. Repeated EEG recordings during wakefulness were normal. During polysomnographic and TV recordings the patients showed different types of dystonic fits occurring several times a night, always brief, and starting during NREM sleep. Carbamazepine therapy proved to be relatively effective in three subjects.
Collapse
Affiliation(s)
- R Silvestri
- First Department of Neurology, University of Messina, Italy
| | | | | | | | | |
Collapse
|